Akari Therapeutics Plc Sponsored ADR
(NASDAQ : AKTX)

( )
AKTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly and Company
1.05%126.561.0%$4598.93m
PFEPfizer Inc.
1.24%42.330.9%$1072.31m
BMYBristol-Myers Squibb Company
-0.50%49.611.4%$1053.18m
JNJJohnson & Johnson
0.94%138.460.7%$909.31m
MRKMerck & Co., Inc.
0.71%81.930.6%$753.98m
ABBVAbbVie, Inc.
0.26%80.862.2%$496.11m
AZNAstraZeneca PLC Sponsored ADR
0.66%42.861.3%$209.38m
NVSNovartis AG Sponsored ADR
-0.18%93.000.2%$160.44m
GSKGlaxoSmithKline plc Sponsored ADR
-0.09%40.460.2%$86.55m
NVONovo Nordisk A/S Sponsored ADR Class B
1.56%52.250.1%$59.07m
SNYSanofi Sponsored ADR
0.51%45.140.2%$51.05m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.53%4.501.6%$24.80m
LCILannett Company, Inc.
2.16%8.0536.7%$11.26m
EPIXESSA Pharma Inc
-1.95%3.520.1%$0.03m

Company Profile

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Coversin, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.